| Enhancer ID: | E_01_0996 |
| Species: | human |
| Position : | chr5:88714648-88716648 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Endometrial cancer |
| Pubmed ID: | 32186750 |
| Enhancer experiment: | RT-qPCR, DNA methylation analysis, cell viability assay, Western blot |
| Enhancer experiment description: | EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed. |
| Target gene : | -- |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed. |
| TF name : | MEF2C(5430401D19Rik,9930028G15Rik,AV011172,Mef2) |
| TF experiment: | RT-QPCR?DNA?????????????Western blot |
| TF experiment description: | EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed. |
| Enhancer function : | EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed. |
| SNP ID: | -- |